Thomas L. Vaughan - Concepedia

Author

Thomas L. Vaughan

Also Known As

Anderson, Lesley A., Bennett, William P., Boccia, S., Chow, Wong Ho, Cook, Michael, Cook, Michael B., Corley, Douglas A, Corley, Douglas A., D C Farrow, Dubrow, Robert

361

Publications

19.1K

Citations

H-Index

190

Concepts

All Affiliations

Fred Hutch Cancer Center University of Washington University of North Carolina at Chapel Hill Yale University National Cancer Institute

About

Thomas L. Vaughan is an author at Fred Hutch Cancer Center specializing in medicine, oncology, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	44	72	7.3K
2	Engineering	2	2	178
3	Health Sciences	2	2	165
4	Nursing	2	2	67
5	Education	1	1	26

Thomas L. Vaughan

161

Publications

15.4K

Citations

H-Index

Page 1

	Year	Citations
Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms Emad El‐Omar, Charles S. Rabkin, Marilie D. Gammon, Gastroenterology EpidemiologyCancer RiskGenetic EpidemiologyGastroenterologyPathology	2003	913
Population Attributable Risks of Esophageal and Gastric Cancers Lawrence S. Engel, W.-H. Chow, Thomas L. Vaughan, JNCI Journal of the National Cancer Institute	2003	787
Body Mass Index and Risk of Adenocarcinomas of the Esophagus and Gastric Cardia Wong‐Ho Chow, William J. Blot, Thomas L. Vaughan, JNCI Journal of the National Cancer Institute	1998	629
An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Wong-Ho Chow, Martin J. Blaser, W J Blot, PubMed Caga+ StrainsEsophagusEsophageal CancerGastric CardiaGastrointestinal Oncology	1998	531
Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Thomas L. Vaughan, Scott Davis, Alan R. Kristal, PubMed Esophageal CancerGastric CardiaSquamous Cell CarcinomaEpidemiology Of CancerCancer Risk Factors	1995	520
Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Diana C. Farrow, Thomas L. Vaughan, Philip D. Hansten, PubMed Anti-inflammatoryAnti-inflammatory AgentsOncologyHealth PolicyGastrointestinal Oncology	1998	417
Cigarette Smoking and Adenocarcinomas of the Esophagus and Esophagogastric Junction: A Pooled Analysis From the International BEACON Consortium Michael B. Cook, Farin Kamangar, David C. Whiteman, JNCI Journal of the National Cancer Institute	2010	317
Central Adiposity and Risk of Barrett’s Esophagus Zoe R. Edelstein, Diana C. Farrow, Mary P. Bronner, Gastroenterology ObesityMetabolic SyndromeEsophagusEsophageal CancerDiabetes	2007	301
Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium Cathrine Hoyo, Michael B. Cook, Farin Kamangar, International Journal of Epidemiology	2012	294
Effect of Segment Length on Risk for Neoplastic Progression in Patients with Barrett Esophagus Rebecca E. Rudolph, Thomas L. Vaughan, Barry E. Storer, Annals of Internal Medicine	2000	272

Page 1